For example, the high expression of BIRC5 can promote the proliferation and angiogenesis of liver cancer cells, reduce the sensitivity to chemotherapy and radiotherapy, and suppress the apoptosis of tumor cells, thereby affecting the survival outcome of HCC patients [18]. Here, BIRC5 is linked to hepatocellular carcinoma.